Dr. Stecher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3101 Western Avenue
Suite 600
Seattle, WA 98121Phone+1 512-522-6126- Is this information wrong?
Education & Training
University of Texas at Austin Dell Medical SchoolResidency, Family Medicine, 2002 - 2005
University of Kansas School of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2004 - 2025
Publications & Presentations
PubMed
- 26 citationsInterleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized stu...Razelle Kurzrock, Tamas Hickish, Lucjan Wyrwicz, Mark P Saunders, Qian Wu, Michael Stecher, Prasant Mohanty, Charles A. Dinarello, John Simard> ;Oncoimmunology. 2019 Jan 1
- 112 citationsMABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 studyTamas Hickish, Thierry André, Lucjan Wyrwicz, Mark P Saunders, Tomasz Sarosiek, Judit Kocsis, Radim Nemecek, Wojciech Rogowski, Krzysztof Lesniewski-Kmak, Lubos Petruz...> ;The Lancet. Oncology. 2017 Feb 1
- 30 citationsA randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revas...Hosam F. El Sayed, Richard Kerensky, Michael Stecher, Prasant Mohanty, Mark G. Davies> ;Journal of Vascular Surgery. 2016 Jan 1
- Join now to see all
Press Mentions
XBiotech : To Deliver Presentation on Novel Study Design and Phase III Results from European Study on Xilonix(TM) During Meeting at the European ParliamentMarch 2nd, 2016
XBiotech to Attend and Present at the ASCO 2016 Gastrointestinal Cancers SymposiumJanuary 21st, 2016
Industry Relationships
- Senior Medical Director, Seagen2019 - Present
- Medical Director, XBiotech2009 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
